World Orphan Drug Congress is the largest global industry gathering for the orphan drug industry and rare disease community where pharma, biotech, patient groups, academia, regulators, payers and investors gather to talk about strategies to expedite orphan drug development.
This year’s WODC will have a whole day seminar on these forward-looking environments: NextGen Therapies featuring Gene Therapy, Biosimilars, Immunotherapy and other up-and-coming biologics; alongside a separate whole-day session on Personalized Medicine.
Nadejda Leavitt, Engagement Manager, Predictive Analytics, Real-World Insights
Stella Blackburn, VP, Global Head of Risk Management
Round Table - Day 1: Using real-world data and advanced analytics to find un-diagnosed patients with rare disease
Dr. Cynthia Jackson, VP & Head of Pediatrics & Rare Disease, Centers of Excellence
Round Table - Day 2: Simplifying the complexities of rare disease drug development